| ［18］ |
Courties A，Sellam J. Osteoarthritis and type 2 diabetes mellitus: what are the links？［J］. Diabetes Res Clin Pract，2016,122: 198-206.
|
| ［19］ |
He M， Lu B， Opoku M，et al. Metformin prevents or delays the development and progression of osteoarthritis: new insight and mechanism of action［J/OL］. Cells， 2022, 11(19): 3012. DOI: 10.3390/cells11193012.
|
| ［20］ |
Yang Y， Wang Y， Kong Y，et al. Carnosine prevents type 2 diabetes-induced osteoarthritis through the ROS/NF-κB pathway［J/OL］. Front Pharmacol， 2018, 9: 598. DOI: 10.3389/fphar.2018.00598.
|
| ［21］ |
Courties A，Gualillo O，Berenbaum F，et al. Metabolic stress-induced joint inflammation and osteoarthritis［J］. Osteoarthritis Cartilage，2015,23(11): 1955-1965.
|
| ［22］ |
Lin S， Lu J， Chen Q，et al. Plantamajoside suppresses the activation of NF-κB and MAPK and ameliorates the development of osteoarthritis［J/OL］. Int Immunopharmacol， 2023, 115: 109582. DOI: 10.1016/j.intimp.2022.109582.
|
| ［23］ |
Griffin TM，Huffman KM. Editorial: insulin resistance: releasing the brakes on synovial inflammation and osteoarthritis？［J］. Arthritis Rheumatol，2016,68(6): 1330-1333.
|
| ［24］ |
Zhang T， Hu L， Tang JF，et al. Metformin inhibits the urea cycle and reduces putrescine generation in colorectal cancer cell lines［J/OL］. Molecules， 2021, 26(7): 1990. DOI: 10.3390/molecules26071990.
|
| ［25］ |
Yerevanian A，Soukas AA. Metformin: mechanisms in human obesity and weight loss［J］. Curr Obes Rep，2019,8(2): 156-164.
|
| ［26］ |
Chinnapaka S， Yang KS， Flowers Q，et al. Metformin improves stemness of human adipose-derived stem cells by downmodulation of mechanistic target of rapamycin（mTOR）and extracellular signal-regulated kinase（ERK）signaling［J/OL］. Biomedicines， 2021, 9(12): 1782. DOI: 10.3390/biomedicines9121782.
|
| ［27］ |
Kim EK， Lee SH， Jhun JY，et al. Metformin prevents fatty liver and improves balance of white/brown adipose in an obesity mouse model by inducing FGF21［J/OL］. Mediators Inflamm， 2016, 2016: 5813030. DOI: 10.1155/2016/5813030.
|
| ［28］ |
Zhang X， Zhao Y， Xu J，et al. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats［J/OL］. Sci Rep， 2015, 5: 14405. DOI: 10.1038/srep14405.
|
| ［29］ |
Björkhem-Bergman L，Asplund AB，Lindh JD. Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis［J］. J Psychopharmacol，2011,25(3): 299-305.
|
| ［30］ |
Le Pelletier L， Mantecon M， Gorwood J，et al. Metformin alleviates stress-induced cellular senescence of aging human adipose stromal cells and the ensuing adipocyte dysfunction［J/OL］. Elife， 2021, 10: e62635. DOI: 10.7554/eLife.62635.
|
| ［31］ |
Valencia WM，Palacio A，Tamariz L，et al. Metformin and ageing: improving ageing outcomes beyond glycaemic control［J］. Diabetologia，2017,60(9): 1630-1638.
|
| ［32］ |
Kulkarni AS， Brutsaert EF， Anghel V，et al. Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults［J/OL］. Aging Cell， 2018, 17(2): e12723. DOI: 10.1111/acel.12723.
|
| ［33］ |
Chen J， Ou Y， Li Y，et al. Metformin extends C. elegans lifespan through lysosomal pathway［J/OL］. Elife， 2017, 6: e31268. DOI: 10.7554/eLife.31268.
|
| ［34］ |
Robinson WH，Lepus CM，Wang Q，et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis［J］. Nat Rev Rheumatol，2016,12(10): 580-592.
|
| ［35］ |
He L. Metformin and systemic metabolism［J］. Trends Pharmacol Sci，2020,41(11): 868-881.
|
| ［36］ |
Yan H， Zhou HF， Hu Y，et al. Suppression of experimental arthritis through AMP-activated protein kinase activation and autophagy modulation［J/OL］. J Rheum Dis Treat， 2015, 1(1): 5. DOI: 10.23937/2469-5726/1510005.
|
| ［37］ |
Tizazu AM， Nyunt MSZ， Cexus O，et al. Metformin monotherapy downregulates diabetes-associated inflammatory status and impacts on mortality［J/OL］. Front Physiol， 2019, 10: 572. DOI: 10.3389/fphys.2019.00572.
|
| ［38］ |
Pickard JM，Zeng MY，Caruso R，et al. Gut microbiota: role in pathogen colonization，immune responses，and inflammatory disease［J］. Immunol Rev，2017,279(1): 70-89.
|
| ［39］ |
Induri SNR，Kansara P，Thomas SC，et al. The gut microbiome，metformin，and aging［J］. Annu Rev Pharmacol Toxicol，2022,62: 85-108.
|
| ［40］ |
He Y， Ren E， Lu Z，et al. Rational engineering of ferritin nanocages for targeted therapy of osteoarthritis［J/OL］. Nanomed-Nanotechnol Biol Med， 2020, 28: 102210. DOI: 10.1016/j.nano.2020.102210.
|
| ［41］ |
Ma T，Tian X，Zhang B，et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2［J］. Nature，2022,603(7899): 159-165.
|
| ［42］ |
Terkeltaub R，Yang B，Lotz M，et al. Chondrocyte AMP-activated protein kinase activity suppresses matrix degradation responses to proinflammatory cytokines interleukin-1β and tumor necrosis factor Α［J］. Arthritis Rheum，2011,63(7): 1928-1937.
|
| ［43］ |
Zhao X，Petursson F，Viollet B，et al. Peroxisome proliferator-activated receptor γ coactivator 1α and FoxO3A mediate chondroprotection by AMP-activated protein kinase［J］. Arthritis Rheumatol，2014,66(11): 3073-3082.
|
| ［44］ |
Sunjaya AP， Sunjaya AF. Targeting ageing and preventing organ degeneration with metformin［J/OL］. Diabetes Metab， 2021, 47(1): 101203. DOI: 10.1016/j.diabet.2020.09.009.
|
| ［45］ |
Akhter N， Wilson A， Arefanian H，et al. Endoplasmic reticulum stress promotes the expression of TNF-α in THP-1 cells by mechanisms involving ROS/CHOP/HIF-1α and MAPK/NF-κB pathways［J/OL］. Int J Mol Sci， 2023, 24(20): 15186. DOI: 10.3390/ijms242015186.
|
| ［46］ |
Xiao SQ，Cheng M，Wang L，et al. The role of apoptosis in the pathogenesis of osteoarthritis［J］. Int Orthop，2023,47(8): 1895-1919.
|
| ［47］ |
Karnewar S，Neeli PK，Panuganti D，et al. Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: relevance in age-associated vascular dysfunction［J］. Biochim Biophys Acta Mol Basis Dis，2018,1864(4 Pt A): 1115-1128.
|
| ［48］ |
Feng K，Chen Z，Liu P，et al. Quercetin attenuates oxidative stress-induced apoptosis via SIRT1/AMPK-mediated inhibition of ER stress in rat chondrocytes and prevents the progression of osteoarthritis in a rat model［J］. J Cell Physiol，2019,234(10): 18192-18205.
|
| ［49］ |
Salvatore T， Pafundi PC， Galiero R，et al. Metformin: a potential therapeutic tool for rheumatologists［J/OL］. Pharmaceuticals， 2020, 13(9): 234. DOI: 10.3390/ph13090234.
|
| ［50］ |
Li J，Zhang B，Liu WX，et al. Metformin limits osteoarthritis development and progression through activation of AMPK signalling［J］. Ann Rheum Dis，2020,79(5): 635-645.
|
| ［51］ |
Zhou S， Lu W， Chen L，et al. AMPK deficiency in chondrocytes accelerated the progression of instability-induced and ageing-associated osteoarthritis in adult mice［J/OL］. Sci Rep， 2017, 7: 43245. DOI: 10.1038/srep43245.
|
| ［52］ |
Fan KJ， Wu J， Wang QS，et al. Metformin inhibits inflammation and bone destruction in collagen-induced arthritis in rats［J/OL］. Ann Transl Med， 2020, 8(23): 1565. DOI: 10.21037/atm-20-3042.
|
| ［53］ |
Wang C， Yao Z， Zhang Y，et al. Metformin mitigates cartilage degradation by activating AMPK/SIRT1-mediated autophagy in a mouse osteoarthritis model［J/OL］. Front Pharmacol， 2020, 11: 1114. DOI: 10.3389/fphar.2020.01114.
|
| ［54］ |
Park MJ，Moon SJ，Baek JA，et al. Metformin augments anti-inflammatory and chondroprotective properties of mesenchymal stem cells in experimental osteoarthritis［J］. J Immunol，2019,203(1): 127-136.
|
| ［55］ |
Na HS， Kwon JY， Lee SY，et al. Metformin attenuates monosodium-iodoacetate-induced osteoarthritis via regulation of pain mediators and the autophagy-lysosomal pathway［J/OL］. Cells， 2021, 10(3): 681. DOI: 10.3390/cells10030681.
|
| ［1］ |
中华医学会骨科学分会关节外科学组，中国医师协会骨科医师分会骨关节炎学组，国家老年疾病临床医学研究中心（湘雅医院），等. 中国骨关节炎诊疗指南（2021年版）［J］. 中华骨科杂志，2021,41(18): 1291-1314.
|
| ［2］ |
Allen KD，Thoma LM，Golightly YM. Epidemiology of osteoarthritis［J］. Osteoarthritis Cartilage，2022,30(2): 184-195.
|
| ［3］ |
Quicke JG，Conaghan PG，Corp N，et al. Osteoarthritis year in review 2021: epidemiology &therapy［J］. Osteoarthritis Cartilage，2022,30(2): 196-206.
|
| ［4］ |
Chen S，Gan D，Lin S，et al. Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms［J］. Theranostics，2022,12(6): 2722-2740.
|
| ［5］ |
张莹莹，李旭东，杨佳娟，等. 中国40岁及以上人群骨关节炎患病率的Meta分析［J］. 中国循证医学杂志，2021,21(4): 407-414.
|
| ［6］ |
Whittaker JL，Losciale JM，Juhl CB，et al. Risk factors for knee osteoarthritis after traumatic knee injury: a systematic review and meta-analysis of randomised controlled trials and cohort studies for the OPTIKNEE Consensus［J］. Br J Sports Med，2022,56(24): 1406-1421.
|
| ［7］ |
Song P， Hwang JS， Park HC，et al. Therapeutic applications of type 2 diabetes mellitus drug metformin in patients with osteoarthritis［J/OL］. Pharmaceuticals， 2021, 14(2): 152. DOI: 10.3390/ph14020152.
|
| ［8］ |
Kloppenburg M，Kroon FP，Blanco FJ，et al. 2018 update of the EULAR recommendations for the management of hand osteoarthritis［J］. Ann Rheum Dis，2019,78(1): 16-24.
|
| ［9］ |
Cai X， Yuan S， Zeng Y，et al. New trends in pharmacological treatments for osteoarthritis［J/OL］. Front Pharmacol， 2021, 12: 645842. DOI: 10.3389/fphar.2021.645842.
|
| ［10］ |
Galicia-Garcia U， Benito-Vicente A， Jebari S，et al. Pathophysiology of type 2 diabetes mellitus［J/OL］. Int J Mol Sci， 2020, 21(17): 6275. DOI: 10.3390/ijms21176275.
|
| ［11］ |
Ruze R， Liu T， Zou X，et al. Obesity and type 2 diabetes mellitus: connections in epidemiology，pathogenesis，and treatments［J/OL］. Front Endocrinol， 2023, 14: 1161521. DOI: 10.3389/fendo.2023.1161521.
|
| ［12］ |
国家老年医学中心，中华医学会老年医学分会，中国老年保健协会糖尿病专业委员会. 中国老年糖尿病诊疗指南（2021年版）［J］. 中华糖尿病杂志，2021,13(1): 14-46.
|
| ［13］ |
Veronese N，Cooper C，Reginster JY，et al. Type 2 diabetes mellitus and osteoarthritis［J］. Semin Arthritis Rheum，2019,49(1): 9-19.
|
| ［14］ |
Louati K， Vidal C， Berenbaum F，et al. Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis［J/OL］. RMD Open， 2015, 1(1): e000077. DOI: 10.1136/rmdopen-2015-000077.
|
| ［15］ |
Miller RE，Miller RJ，Malfait AM. Osteoarthritis joint pain: the cytokine connection［J］. Cytokine，2014,70(2): 185-193.
|
| ［16］ |
Berenbaum F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype［J］. Ann Rheum Dis，2011,70(8): 1354-1356.
|
| ［17］ |
Katsiki N，Mikhailidis DP，Banach M. Leptin，cardiovascular diseases and type 2 diabetes mellitus［J］. Acta Pharmacol Sin，2018,39(7): 1176-1188.
|
| ［56］ |
Guo H， Ding D， Wang L，et al. Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway［J/OL］. PLoS One， 2021, 16(12): e0261127. DOI: 10.1371/journal.pone.0261127.
|
| ［57］ |
Belenska-Todorova L， Lambova SN， Stoyanova S，et al. Disease-modifying potential of metformin and alendronate in an experimental mouse model of osteoarthritis［J/OL］. Biomedicines， 2021, 9(8): 1017. DOI: 10.3390/biomedicines9081017.
|
| ［58］ |
Li H， Gou Y， Tian F，et al. Combination of metformin and exercise alleviates osteoarthritis in ovariectomized mice fed a high-fat diet［J/OL］. Bone， 2022, 157: 116323. DOI: 10.1016/j.bone.2021.116323.
|
| ［59］ |
Lu CH， Chung CH， Lee CH，et al. Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: a nationwide，retrospective，matched-cohort study in Taiwan［J/OL］. PLoS One， 2018, 13(1): e0191242. DOI: 10.1371/journal.pone.0191242.
|
| ［60］ |
Wang Y， Hussain SM， Wluka AE，et al. Association between metformin use and disease progression in obese people with knee osteoarthritis: data from the Osteoarthritis Initiative-a prospective cohort study［J/OL］. Arthritis Res Ther， 2019, 21(1): 127. DOI: 10.1186/s13075-019-1915-x.
|
| ［61］ |
Barnett LA，Jordan KP，Edwards JJ，et al. Does metformin protect against osteoarthritis？An electronic health record cohort study［J］. Prim Health Care Res Dev，2017,18(6): 623-628.
|